The ophthalmic devices market size is projected to reach US$ 73.99 billion by 2031 from US$ 40.48 billion in 2023; the market is estimated to record a CAGR of 7.8% during 2023–2031.
Ophthalmic devices are medical equipment used for vision correction, diagnosis, and surgical purposes. The awareness and adoption of ophthalmic devices have surged in recent years due to an upsurge in cases of glaucoma, cataracts, and other vision-related illnesses. The rising geriatric population and surging prevalence of optical disorders are projected to bolster the ophthalmic devices market in the coming years. The ophthalmic devices market trends include technological advancements in ophthalmic devices that will favor the growth of the market in the future.
Growth Drivers:
An upsurge in the geriatric population in developed countries such as the US, the UK, Canada, and Japan, and developing countries such as China, India, and South Korea is driven by the modernization of healthcare facilities and improvements in healthcare services, which has improved the life expectancy in these countries. The aging population has a heavy impact on the social and economic fronts in the world. New techniques are being adopted in various countries across the world to safely and effectively treat the elderly populations. Thus, the increased quality of life has resulted in decreased death rates, in turn causing a surge in the geriatric population. According to the World Health Organization 2022 data, 1 out of every 6 persons will be aged 60 years and above by 2030; the population of people aged 60 and above is expected to grow from 900 million in 2021 to 2 billion by 2050. The percentage of the worldwide population in this age group will double from 12% in 2015 to 22% by 2050. As per the Department of Economic and Social Affairs, the United Nations report for 2019, ~703 million individuals are aged 65 years and above, and the number is estimated to double to 1.5 billion by 2050.
Glaucoma is a prominent cause of blindness among people aged 60 and above, and people are six times more likely to develop glaucoma after reaching the age of 60. As per the National Glaucoma Research Fact Sheet 2022, more than 3 million Americans have glaucoma, out of which 2.7 million people living with the condition are aged 40 and older. The other causes of blindness include diabetic retinopathy, age-related macular degeneration, and retinal detachment. The Centers for Disease Control and Prevention states that the prevalence of diabetic retinopathy was lowest among people younger than 25 years (13.0%) and highest among people from the age group of 65–79 (28.4%) in the US in 2021. Age-related eye diseases are also cited as the leading causes of blindness and low vision in the US. Thus, the aging population is more susceptible to various ocular diseases that require early diagnosis and treatment, which, in turn, drives the demand for ophthalmic devices, contributing to the ophthalmic devices market growth.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Ophthalmic Devices Market: Strategic Insights

- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Ophthalmic Devices Market: Strategic Insights

- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Report Segmentation and Scope:
The ophthalmic devices market analysis has been carried out by considering the following segments: product, indication, end user, and geography. Based on product, the market is segmented into vision care products, surgical devices, and diagnostics and monitoring devices. In terms of indication, the market is classified into cataract, glaucoma, refractor disorders, and other indications. Based on end user, the market is categorized into hospitals and eye clinics, academic and research laboratories, and other end users. The scope of the ophthalmic devices market report covers North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Segmental Analysis:
The ophthalmic devices market, by product, is categorized into vision care products, surgical devices, and diagnostics and monitoring devices. The vision care products segment held a significant market share in 2023. It is anticipated to record the highest CAGR in the market during 2023–2031.
Based on indication, the market is categorized into cataract, glaucoma, refractor disorders, and other indications. The glaucoma segment held a significant ophthalmic devices market share in 2023 and is estimated to register the highest CAGR during 2023–2031.
Based on end user, the market is segmented into hospitals and eye clinics, academic and research laboratories, and other end users. The hospital and eye clinics segment held a significant ophthalmic devices market share in 2023 and is expected to register the highest CAGR during 2023–2031.
Regional Analysis:
In terms of geography, the ophthalmic devices market is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2023, North America captured a significant share of the market. In 2023, the US dominated the ophthalmic devices market in this region. The market growth in North America is attributed to the growing burden of eye diseases, such as cataracts, glaucoma, diabetic retinopathy, age-related macular degeneration (AMD), and refractive diseases; increasing geriatric population; the surging acceptance of technologically advanced ophthalmic devices; and the presence of significant market players in the region. With the surging population of people aged 65 and above, cases of age-related diseases such as AMD are on the rise in the US. According to the National Institutes of Health report, the number of people with AMD rose by 18% from 2000–2010, reaching 2.07 million by 2010 from 1.75 million in 2000. By 2050, the number is projected to reach 5.44 million from 2.07 million. According to the study “Prevalence of Diabetic Retinopathy in the US in 2021,” published in 2023, ~9.6 million people were living with diabetic retinopathy, and ~1.8 million people were living with vision-threatening diabetic retinopathy in 2021 in the US. This leads to a greater demand for diagnostic ophthalmic tools, thereby propelling the ophthalmic devices market growth in the region.
Ophthalmic Devices Market Regional Insights
The regional trends and factors influencing the Ophthalmic Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Ophthalmic Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

- Get the Regional Specific Data for Ophthalmic Devices Market
Ophthalmic Devices Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 40.48 Billion |
Market Size by 2031 | US$ 73.99 Billion |
Global CAGR (2023 - 2031) | 7.8% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Ophthalmic Devices Market Players Density: Understanding Its Impact on Business Dynamics
The Ophthalmic Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Ophthalmic Devices Market are:
- Alcon,
- Topcon,
- Bausch + Lomb,
- Carl Zeiss Meditec,
- Haag Streit Holding,
- Essilor,
Disclaimer: The companies listed above are not ranked in any particular order.

- Get the Ophthalmic Devices Market top key players overview
Industry Developments and Future Opportunities:
The ophthalmic devices market report includes company positioning and concentration to evaluate the performance of competitors in the market. As per company press releases, a few initiatives taken by key players operating in the market are mentioned below:
- In July 2021, Topcon Corporation acquired VISIA Imaging S.r.l, an ophthalmic device manufacturer headquartered in suburban Florence, Italy. With the acquisition, Topcon intends to further strengthen its well-positioned portfolio of fundus imaging devices—which includes fundus cameras and optical coherence tomography. This acquisition enhances Topcon’s development and production capabilities of anterior segment devices and software. The acquisition is also meant to strengthen Topcon's standing as a top producer of ophthalmic diagnostic tools.
- In March 2021, Iridex Corporation entered into a strategic collaboration with Topcon Corporation. Iridex Corporation is a renowned provider of innovative ophthalmic laser-based medical products for treating glaucoma and retinal diseases. Iridex acquired Topcon’s PASCAL product line, combining its own MicroPulse technology with Topcon’s PASCAL laser platform, to expand its share in the market for retinal scanning laser products.
Competitive Landscape and Key Companies:
The ophthalmic devices market forecast can help stakeholders plan their growth strategies. Alcon, Topcon, Bausch + Lomb, Carl Zeiss Meditec, Haag Streit Holding, Essilor, Johnson & Johnson Vision, Nidek Co. Ltd, Hoya Corporation, and CooperVision are among the prominent players profiled in the market. These companies focus on introducing new high-tech products, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.
Frequently Asked Questions
What was the estimated ophthalmic devices market size in 2023?
The ophthalmic devices market was valued at US$ 40.48 billion in 2023.
Which segment is dominating the ophthalmic devices market?
The global ophthalmic devices market is segmented based on by product, indication, and end user. The ophthalmic devices market, by product, is categorized into vision care products, surgical devices, and diagnostics and monitoring devices. The vision care products segment held a significant market share in 2023 and is anticipated to record the highest CAGR in the market during 2023–2031.
Who are the major players in the ophthalmic devices market?
The ophthalmic devices market majorly consists of the players, including Alcon, Topcon, Bausch + Lomb, Carl Zeiss Meditec, Haag Streit Holding, Essilor, Johnson & Johnson Vision, Nidek Co. Ltd, Hoya Corporation, and CooperVision.
What is the driving and restraining factors for the ophthalmic devices market?
The factors driving the growth of the ophthalmic devices market include the increasing prevalence of optical disorders and the growing geriatric population. However, high cost of devices hampers the growth of the ophthalmic devices market.
What are the growth estimates for the ophthalmic devices market till 2031?
The ophthalmic devices market is expected to be valued at US$ 73.79 billion in 2031.
What are ophthalmic devices?
The ophthalmic devices are used for diagnosis, surgical, and vision correction purposes. These devices include invasive devices such as implantable devices (intraocular lenses and glaucoma stents), and noninvasive diagnostic equipment and instruments. The adoption of these devices has increased due to increasing cases of glaucoma, cataract, and other vision-related issues worldwide.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















The List of Companies - Ophthalmic Devices Market
- Alcon
- Topcon Corp.
- Bausch + Lomb
- Carl Zeiss Meditec
- Haag?Streit Holding
- Essilor
- Johnson & Johnson Vision
- Nidek Co. Ltd
- Hoya Corporation
- CooperVision.


